Related Experiment Video
Updated: Mar 12, 2026

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
Molecular imaging of the kidney in lupus nephritis to characterize response to treatment
Samir V Parikh1, Ana Malvar2, Huijuan Song1
1Division of Nephrology, The Ohio State University Wexner Medical Center, Columbus, Ohio.
Abstract:
The consequences of treatment for the kidney at the molecular level have not been explored in human lupus nephritis (LN). In this investigation, changes in intrarenal transcript expression were measured and correlated with response in a LN cohort that underwent serial kidney biopsies. The intrarenal transcript expression of 19 patients with proliferative LN (Class III or IV) was measured at diagnostic biopsy (Bx1) and after induction therapy was completed (Bx2) using Nanostring technology. Patients were segregated by clinical response into complete responders (n = 5, CR) or nonresponders (n = 4, NR). Transcript expression for each biopsy was compared with normal controls (n = 4), and the change in expression was compared in each responder group and between groups. Compared with controls, the CR group had 21 and 28, whereas NR had 45 and 103 differentially-expressed transcripts at Bx1 and Bx2, respectively. The profiles of these differentially-expressed genes indicated that the type I and II interferon, alternative complement and T cell signaling pathways discriminated CR from NR. Comparing the change in transcript expression from Bx1 to Bx2 revealed a 5-gene signature that differentiated NR from CR and included increased IL1RAP and FCAR in NR and increased NCAM1 in CR. In summary, molecular imaging of serial kidney biopsies from LN patients shows several immune and inflammatory pathways that are dysregulated in the kidneys during active disease that may serve as therapeutic targets to improve clinical response. This approach to LN biomarker development may facilitate personalized medicine in LN and improve long-term kidney outcomes.
Insights
Molecular analysis of kidney biopsies in lupus nephritis (LN) reveals distinct immune and inflammatory pathways. Identifying these molecular signatures can guide personalized medicine and improve treatment response in LN patients.
Area of Science:
- Nephrology
- Immunology
- Molecular Biology
Background:
- Molecular changes in kidney tissue during lupus nephritis (LN) treatment remain underexplored in humans.
- Understanding intrarenal transcript expression is crucial for correlating molecular alterations with treatment response.
Purpose of the Study:
- To investigate changes in intrarenal transcript expression in patients with lupus nephritis (LN) undergoing treatment.
- To correlate these molecular changes with clinical response to induction therapy.
- To identify potential molecular biomarkers for personalized medicine in LN.
Main Methods:
- Serial kidney biopsies (Bx1 at diagnosis, Bx2 post-therapy) were obtained from 19 patients with proliferative LN (Class III/IV).
- Nanostring technology was used to measure intrarenal transcript expression.
- Patients were classified as complete responders (CR) or nonresponders (NR) based on clinical outcomes.
- Transcript expression was compared between patient groups and normal controls.
Main Results:
- Significant differences in differentially-expressed transcripts were observed between LN patients and controls at both biopsy time points.
- Immune and inflammatory pathways, including type I/II interferon, alternative complement, and T cell signaling, distinguished CR from NR.
- A 5-gene signature, including IL1RAP, FCAR, and NCAM1, differentiated NR from CR based on changes in transcript expression from Bx1 to Bx2.
Conclusions:
- Molecular profiling of serial kidney biopsies reveals dysregulated immune and inflammatory pathways in active lupus nephritis (LN).
- These pathways represent potential therapeutic targets to enhance clinical response in LN.
- This molecular imaging approach aids in LN biomarker development for personalized treatment strategies and improved kidney outcomes.
Related Concept Videos
Imaging Studies I: Kidney, Ureter, and Bladder Studies
Imaging Studies II: Ultrasonography
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Imaging Studies VII: Vascular Imaging
Imaging Studies IV: Magnetic Resonance Imaging
Imaging Studies V: Intravenous Urography and Retrograde Pyelography

